Browse

S-Space

Browsing by Author Kim, Se Hyun

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 54 of 54

Issue Date Title / Author(s) / CitationFileAltmetrics
2005-05
Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection

Ahn, Yong Min; Seo, Myoung Suk; Kim, Se Hyun; Kim, Yeni; Yoon, Se Chang; Juhnn, Yong-Sung; Kim, Yong Sik

Int J Neuropsychopharmacol. 2005 Dec;8(4):607-13. Epub 2005 May 9.

view filelink
2005-08
The effects of MK-801 on the phosphorylation of Ser338-c-Raf-MEK-ERK pathway in the rat frontal cortex

Ahn, Yong Min; Seo, Myoung Suk; Kim, Se Hyun; Kim, Yeni; Juhnn, Yong-Sung; Kim, Yong Sik

Int J Neuropsychopharmacol. 2006 Aug;9(4):451-6. Epub 2005 Aug 4.

view filelink
2006
The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex
view filelink
2006-03
Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells

Shin, Soon Young; Choi, Byeong Hyeok; Ko, Jesang; Kim, Se Hyun; Kim, Yong Sik; Lee, Young Han

Cell Signal. 2006 Nov;18(11):1876-86. Epub 2006 Mar 6.

link
2008-02
The effect of MK-801 on mTOR/p70S6K and translation-related proteins in rat frontal cortex
link
2008-02
Haloperidol regulates the phosphorylation level of the MEK-ERK-p90RSK signal pathway via protein phosphatase 2A in the rat frontal cortex
view fileDOI
2008-07
Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity

Kim, Se Hyun; Yu, Hyun-Sook; Park, Hong Geun; Jeon, Won Je; Song, Joo Yun; Kang, Ung Gu; Ahn, Yong Min; Lee, Young Han; Kim, Yong Sik

Prog Neuropsychopharmacol Biol Psychiatry. 2008 ;32(7):1637-42.

link
2009-04
The Effect of Neontal MK-801 Treatment on ERK1/2-p70S6K-S6 Signal Pathway and Protein Synthesis Rate in the Frontal Cortex of Developing Rat Brain

Kim, Yong Sik; Kim, Se Hyun; Park, Hong Geun

BIOLOGICAL PSYCHIATRY; Vol.65(8); 42S-42S

2009-05
Reduction in the protein level of c-Jun and phosphorylation of Ser73-c-Jun in rat frontal cortex after repeated MK-801 treatment
DOI
2009-06
AKT1 Gene Polymorphisms and Obstetric Complications in the Patients with Schizophrenia
view fileDOI
2009-07
Causal model of insight and psychopathology based on the PANSS factors: 1-year cross-sectional and longitudinal revalidation

Hwang, Samuel Suk-Hyun; Chang, Jae Seung; Lee, Kyu Young; Kim, Se Hyun; Kim, Yong Sik; Ahn, Yong Min

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY; Vol.24(4); 189-198

DOI
2009-11
Effects of electroconvulsive shock on the phosphorylation of DARPP-32 in rat striatum
DOI
2010-03
No association between AKT1 polymorphism and schizophrenia: A case-control study in a Korean population and a meta-analysis
DOI
2010-03
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia

Hwang, Samuel Suk-Hyun; Jung, Dong Chung; Kim, Se Hyun; Ahn, Yong Min; Kim, Yong Sik

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY; Vol.25 2; 83-90

DOI
2010-05
The Replication of Egr3 as a Potential Susceptibility Gene for Schizophrenia in Korean Patients with Schizophrenia
2010-07
The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series

Kim, Se Hyun; Jung, Dong Chung; Ahn, Yong Min; Kim, Yong Sik

JOURNAL OF PSYCHOPHARMACOLOGY; Vol.24 7; 981-986

DOI
2010-08
Activation of Akt signaling in rat brain by intracerebroventricular injection of ouabain: A rat model for mania

Yu, Hyun-Sook; Kim, Se Hyun; Park, Hong Geun; Kim, Yong Sik; Ahn, Yong Min

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY; Vol.34 6; 888-894

DOI
2010-08
The usefulness of a self-report questionnaire measuring auditory verbal hallucinations

Kim, Se Hyun; Jung, Hee Yeon; Hwang, Samuel S.; Chang, Jae Seung; Ahn, Yong Min; Kim, Yong Sik; Kim, Yeni

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY; Vol.34 6; 968-973

DOI
2010-10
Effects of neonatal MK-801 treatment on p70S6K-S6/eIF4B signal pathways and protein translation in the frontal cortex of the developing rat brain

Kim, Se Hyun; Park, Hong Geun; Kim, Han Soo; Ahn, Yong Min; Kim, Yong Sik

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY; Vol.13 9; 1233-1246

view fileDOI
2010-10
EGR3 as a Potential Susceptibility Gene for Schizophrenia in Korea

Kim, Se Hyun; Song, Joo Yun; Joo, Eun-Jeong; Lee, Kyu Young; Kim, Yong Sik; Ahn, Yong Min

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS; Vol.153B 7; 1355-1360

DOI
2010-10
Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea`s general population

Lee, Nam Young; Kim, Se Hyun; Cho, Belong; Lee, Yeon Ji; Kang, Ung Gu; Ahn, Yong Min; Kim, Yong Sik; Chang, Jae Seung

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY; Vol.34 7; 1243-1249

DOI
2010-10
Association between CLOCK 3111T/C and preferred circadian phase in Korean patients with bipolar disorder

Lee, Kyu Young; Song, Joo Yun; Kim, Se Hyun; Kim, Seong Chan; Ahn, Yong Min; Kim, Yong Sik; Joo, Eun-Jeong

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY; Vol.34 7; 1196-1201

DOI
2014-03
Charge transport and morphology of pentacene films confined in nano-patterned region

Kim, Tae-Sik; Kim, Se Hyun; Jang, Mi; Yang, Hoichang; Lee, Tae-Woo

NPG Asia Materials, Vol.6 No.3, p. e91

DOI
2015-06
Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer

Sim, Sung Hoon; Kim, Yu Jung; Kim, Se Hyun; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok

Journal of Cancer Research and Clinical Oncology, Vol.141 No.6, pp.1073-1081

DOI
2015-10
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations
view fileDOI
2016-10
Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of doxorubicin/cyclophosphamide followed by docetaxel in breast cancer: A multicenter retrospective cohort study
DOI
2017-04
Room-Temperature-Processable Wire-Templated Nanoelectrodes for Flexible and Transparent All -Wire Electronics
DOI
2017-04
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results
DOI
2017-09
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas
DOI
2017-09
EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
DOI
2017-10
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
DOI
2017-11
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer
DOI
2017-12
Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study
DOI
2018-02
Phase I pharmacokinetic study of nivolumab in Korean patients with advanced solid tumors
DOI
2018-03
Efficacy of pemetrexed-based chemotherapy in comparison to non-pemetrexed-based chemotherapy in advanced, ALK plus non-small cell lung cancer
view fileDOI
2018-03
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody
DOI
2018-08
차명거래 규제에 관한 연구
view file
2018-08
Low-dose nivolumab can be effective in non-small cell lung cancer: Alternative option for financial toxicity
DOI
2018-11
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study)
DOI
2018-12
A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial
DOI
2019-01
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
view fileDOI
2019-05
Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)
view fileDOI
2019-10
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer
DOI
2019-11
The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer
view fileDOI
2020-07
Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors
view fileDOI
2020-12
A perspective on semiconductor devices based on fluorite-structured ferroelectrics from the materials-device integration perspective
DOI
2021-10
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma Who Received Systemic Treatment
2022-01
Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study
DOI
2022-04
Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
DOI
2022-04
Performance of clinician prediction of survival in oncology outpatients with advanced cancer
DOI
2022-04
A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
2022-06
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer
2022-07
The association between changes in symptoms or quality of life and overall survival in outpatients with advanced cancer
DOI
2022-11
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy
1

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr youtube

RSS 1.0 RSS 2.0 Atom

Hello

Browse

News About S-Space Seoul National University Library LOGIN